Showing 2341-2350 of 21408 results for "".
- Innovations in Obesity Management: The Clinical Impact of Tirzepatidehttps://reachmd.com/news/innovations-in-obesity-management-the-clinical-impact-of-tirzepatide/2475403/Although global obesity rates continue to rise, innovative pharmacological agents such as tirzepatide are capturing clinical attention for their ability to suppress appetite and drive substantial weight loss, complementing existing lifestyle
- High Defect Rate of Cancer Medications in Sub-Saharan Africa: Urgent Need for Innovative Solutionshttps://reachmd.com/news/high-defect-rate-of-cancer-medications-in-sub-saharan-africa-urgent-need-for-innovative-solutions/2475404/The high defect rate of cancer medications in sub-Saharan Africa is directly impacting patient outcomes and safety, demanding urgent attention and innovative responses. Research from the University of Notre Dame highlights that 1 in 6
- Novel Biomarkers for Early Detection and Intervention in Psychosis and Depressionhttps://reachmd.com/news/novel-biomarkers-for-early-detection-and-intervention-in-psychosis-and-depression/2475398/Exploring novel biomarkers for early detection and improved intervention in psychosis and depression, recent data highlight grip strength and inflammatory profiles as windows into psychiatric pathophysiology. Distinguishing incipient p
- The Evolving Role of JAK Inhibitors: Upadacitinib’s Impact on Giant Cell Arteritishttps://reachmd.com/news/the-evolving-role-of-jak-inhibitors-upadacitinibs-impact-on-giant-cell-arteritis/2475405/Upadacitinib, a Janus kinase (JAK) inhibitor, has shown efficacy in managing giant cell arteritis by achieving sustained remission in clinical trials, potentially providing an alternativ
- Advanced Imaging and Optical Strategies in Predicting Myopia Progressionhttps://reachmd.com/news/advanced-imaging-and-optical-strategies-in-predicting-myopia-progression/2475410/A recent longitudinal study published June 16, 2025, in the American Journal of Ophthalmology offers new insights into how peripheral vision may influe
- AI Innovations Reshape Radiology: Breast Cancer and MRI Breakthroughshttps://reachmd.com/news/ai-innovations-reshape-radiology-breast-cancer-and-mri-breakthroughs/2475402/Radiologists seeking to close diagnostic blind spots in both breast cancer detection and MRI scans are increasingly leveraging AI diagnostic tools, as recent findings from AI for breast cancer detection reveal its capacity to detect and local
- ADC189 and Beyond: Revolutionizing Antiviral Treatment with Innovative Solutionshttps://reachmd.com/news/adc189-and-beyond-revolutionizing-antiviral-treatment-with-innovative-solutions/2475326/In the context of evolving viral threats and rising resistance, ADC189 has shown promise as a single-dose influenza treatment by achieving a significant viral load reduction, highlighting the need for innovative antiviral solutions. Fo
- Integrating Genetic Ancestry and Precision Oncologyhttps://reachmd.com/news/integrating-genetic-ancestry-and-precision-oncology/2475328/In the field of oncology, genetic profiling allows for more tailored treatments to individuals' genetic profiles, which is helping to refine prognosis and therapy strategies. Clinicians are confronted with striking variability in outco
- Evolving Strategies in ACL Reconstruction: New Grafts and Rehabilitation Insights for Improved Outcomeshttps://reachmd.com/news/evolving-strategies-in-acl-reconstruction-new-grafts-and-rehabilitation-insights-for-improved-outcomes/2475325/As orthopedic surgeons confront persistent challenges in restoring knee stability, recent research by Janne Spierings on bare ACL graft protocols offers promising insights into anterior cruciate ligament reconstruction outcomes. Persis
- Advanced PET Imaging in Cardiology: Early Detection and Intervention for Non-Ischemic Myocardial Injuryhttps://reachmd.com/news/advanced-pet-imaging-in-cardiology-early-detection-and-intervention-for-non-ischemic-myocardial-injury/2475333/Advanced PET imaging techniques are enhancing cardiology by detecting early non-ischemic myocardial injury through fibroblast activation, facilitating timely intervention before irreversible remodeling. Non-ischemic cardiomyopathy pres